Related Experiment Video
Updated: Mar 27, 2026

03:42
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
2.2K
Pulsed Low-Dose-Rate Chemoradiation Induces Stromal Reprogramming in Pancreatic CAF-Generated ECM: Quantification by
Janusz Franco-Barraza1,2, Mariia Dmitrieva1,2, Tiffany Luong1,2
1Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Gastro Hep Advances
|March 26, 2026
Summary
Pulsed low-dose-rate radiation (PLDR) may limit pancreatic cancer desmoplasia by altering the tumor microenvironment. A new tool, HOST-Factor, quantifies stromal function to guide treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Radiotherapy Research
Background:
- Pancreatic cancer is lethal due to its complex desmoplastic tumor microenvironment (TME).
- Conventional chemoradiation has pro-tumoral effects on the TME.
- Novel therapeutic strategies are needed to overcome TME-driven resistance.
Purpose of the Study:
- To investigate pulsed low-dose-rate radiation (PLDR) as an alternative to conventional radiotherapy.
- To evaluate PLDR's impact on the TME in pancreatic cancer.
- To develop a novel method for quantifying stromal function in vitro.
Main Methods:
- Utilized a 3D cancer-associated fibroblast (CAF) functional unit culture system.
- Developed the Harmonic Output of Stromal Traits Factor (HOST-Factor) to assess stromal biomarkers.
- Modeled and altered TME behavior in vitro.
Main Results:
- PLDR combined with chemotherapy shifted the extracellular matrix (ECM) produced by CAFs.
- PLDR-treated CAFs produced ECMs that restricted further CAF activation.
- A shift in HOST-Factor values correlated with ECM's restrictive phenotype.
Conclusions:
- PLDR may restrict pancreatic cancer desmoplasia and enhance chemoradiotherapy efficacy.
- HOST-Factor offers a quantitative tool for assessing stromal function.
- Findings support ongoing clinical trials evaluating PLDR-based chemoradiation.

